Hypertrophic Cardiomyopathy Treatment in Turkey
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Hypertrophic Cardiomyopathy?
Hypertrophic cardiomyopathy is a heart muscle disease characterised by abnormal thickening of the ventricular walls. In some patients, the thickened muscle obstructs blood flow; in others, the disease is non-obstructive. HCM can be inherited and may occur at different ages.
What is the Importance of Timely Treatment?
Timely treatment of Hypertrophic Cardiomyopathy helps control symptoms, assess whether thickened heart muscle is obstructing blood flow, reduce the risk of complications such as heart failure and arrhythmias, and identify patients who may benefit from an implantable cardioverter-defibrillator (ICD). Regular follow-up also supports long-term heart health by guiding medicines, activity, lifestyle, and family screening.
What are the Common Symptoms of Hypertrophic Cardiomyopathy?
- Shortness of Breath: Breathlessness may occur during physical activity or, in more advanced cases, at rest.
- Chest Pain: Some patients experience chest discomfort, particularly during exertion.
- Palpitations: A sensation of a racing, pounding, or irregular heartbeat may occur because of abnormal heart rhythms.
- Dizziness: Reduced cardiac output or abnormal rhythms may cause lightheadedness, particularly during activity.
- Fainting: Episodes of unexplained fainting may occur and require medical evaluation, especially in people with known HCM.
- Fatigue: Reduced ability of the heart to fill or pump efficiently can lead to tiredness and reduced exercise tolerance.
Causes and Risk Factors of Hypertrophic Cardiomyopathy
Causes
- Inherited Genetic Changes: Most familial HCM is linked to genetic variants that affect proteins involved in heart muscle contraction.
- Spontaneous Genetic Changes: Some patients develop HCM without a known family history.
- Unexplained Causes: In some individuals, no specific genetic or other cause is identified.
- Associated Conditions: Some heart-muscle disorders can produce thickening that resembles HCM and require careful evaluation to distinguish them from true HCM.
Risk Factors
- Family History: Having a first-degree relative with HCM or unexplained sudden cardiac death can increase risk.
- Genetic Predisposition: Inherited disease-causing variants can increase susceptibility.
- Age: HCM can become apparent during childhood, adolescence, adulthood, or later life.
- Previous Abnormal Cardiac Findings: Unexplained heart-muscle thickening or abnormal ECG findings may prompt further assessment.
- Family History of Sudden Cardiac Death: This may be an important factor in individual risk assessment.
Latest Research and Technologies in the Treatment of Hypertrophic Cardiomyopathy in Turkey
- Recent advances in HCM care include cardiac MRI for detailed assessment of heart muscle thickness and scar tissue, advanced echocardiography for evaluating blood-flow obstruction, and genetic testing for selected patients and families. Newer cardiac myosin inhibitors, provide a targeted treatment option for selected adults with symptomatic obstructive HCM. Advanced risk assessment also helps identify patients who may benefit from ICDs, while specialised centres can offer septal reduction procedures, including surgical myectomy and selected catheter-based approaches.
Treatment options for Hypertrophic Cardiomyopathy
Septal Myectomy: This open-heart surgical procedure (Morrow procedure) remains the gold-standard intervention to physically excise a portion of the hypertrophied septum and relieve left ventricular outflow tract (LVOT) obstruction.
Alcohol Septal Ablation: A minimally invasive, catheter-based alternative to surgery where pure alcohol is injected into a septal branch artery to induce a localised controlled infarction, thinning the muscle to reduce obstruction.
Implantable Cardioverter-Defibrillator (ICD) : some HCM patients have an increased risk of sudden cardiac death, and ICD decisions are based on individual risk assessment.
Cost Start From 20000Explore Options
Heart Transplantation : For the small percentage of HCM patients who progress to end-stage, non-obstructive "burnt-out" heart failure, an orthotopic heart transplant is the final definitive option
- Clinical assessment:
- Medical and Family History: Assessment of symptoms, exercise tolerance, previous fainting, family history of HCM, and sudden cardiac death.
- Physical Examination: Evaluation for heart murmurs, abnormal heart sounds, blood pressure changes, and signs of heart failure.
- Electrocardiogram (ECG): May identify abnormal electrical patterns associated with HCM.
- Holter or Ambulatory ECG Monitoring: Detects intermittent arrhythmias that may not appear on a standard ECG.
- Exercise Testing: May assess exercise capacity, blood pressure response, symptoms, and exercise-related obstruction.
- Genetic Testing: May be offered to selected patients to identify disease-causing variants and support family screening.
- Imaging Tests:
- Echocardiography: The main imaging test used to assess heart-muscle thickness, heart function, valve movement, and obstruction.
- Cardiac MRI: Provides detailed images of heart structure and can identify myocardial scar and other tissue characteristics.
- Stress Echocardiography: May reveal obstruction or abnormalities that become apparent during exercise.
- Chest X-ray: May help evaluate heart size and associated lung findings when clinically indicated.
- Cardiac CT: Consider in selected patients when additional anatomical information is needed.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support hypertrophic cardiomyopathy patients in Turkey. These services include:
- Individualised Exercise: Specialists can recommend appropriate physical activity based on symptoms, disease severity, and individual needs.
- Cardiac Rehabilitation: Selected patients may benefit from structured, supervised rehabilitation.
- Physical Conditioning: Gradual activity can help maintain functional capacity while avoiding inappropriate exertion.
- Weight Management: Maintaining a healthy weight can reduce additional cardiovascular strain.
- Long-Term Follow-Up: Regular cardiology assessments help monitor symptoms, heart function, rhythm, and response to treatment.
- Select medicines based on symptoms, obstruction, heart rhythm, and overall heart function. Beta-blockers and certain calcium-channel blockers may help reduce symptoms and improve ventricular filling. Selected patients with obstructive HCM may receive cardiac myosin inhibitors, while antiarrhythmic or anticoagulant medicines may be prescribed when clinically indicated. Treatment should be supervised by a cardiologist experienced in HCM.
Instantly Connect with our Specialists
Hospitals for Hypertrophic Cardiomyopathy in Turkey
Ekol
Izmir, Turkey
Ekol Hospitals, located in Izmir, Turkey, offers a revolutionary approach to healthcare with its unique integrated model. The hospital is made up of two general hospitals and three specialized medical centers, boasting a total of 250 beds. With a team of 130 highly qualified surgeons and over 500 healthcare professionals, Ekol Hospitals is equipped with state-of-the-art technology to provide exceptional care. The hospital’s Health and Rehabilitation Centre, which was acquired from a hotel space, ensures a comfortable and convenient environment for patients, offering both excellent medical services and access to local attractions. Ekol Hospitals proudly serves a diverse international clientele, with medical staff fluent in English, German, French, and Turkish, and offers competitively priced treatment options. Accredited by respected global agencies, Ekol Hospitals is committed to delivering top-tier healthcare to patients from around the world.
Anadolu Medical Center
Kocaeli, Turkey
Anadolu Medical Center located in Kocaeli, Turkey is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:
- The Medical Center is present over an area of 188.000 square meters. This is inclusive of the indoor area which is 50 thousand square meters.
- Let us also have a look at some of the important infrastructure pointers of this hospital.
- Bed capacity of 201
- Outpatient Clinic at Ata?ehir
- Bone Marrow Transplantation Center that opened its doors in June 2010
- Developed and using latest technologies such as IMRT and Cyberknife
- Multidisciplinary care
- An OECI-designated clinical cancer centre
Biruni University Hospital
Istanbul, Turkey
Biruni University Hospital started to serve in 2016. It is a full-fledged multi-specialty healthcare facility, situated in Istanbul, Turkey. The hospital is well-known for its outstanding medical care standards, and it has acquired numerous certificates from international quality organizations. It is a renowned & well-established healthcare facility that provides cutting-edge diagnostic and treatment approaches. They have a team of highly skilled doctors and surgeons on call 24 hours a day, seven days a week to deliver the best medical care possible.
The hospital has various medical departments such as Cardiology, Neurology, Urology, Rheumatology, Pediatrics, General Medicine and Surgery, Gastroenterology, etc. Popular treatments conducted at the hospital are Pediatric Neurology, Cardiac Stenting, Balloon Angioplasty, Bypass surgery, plastic surgery procedures like Hair transplant, & Botox injections, and many more. The hospital is known for its most valuable service i.e. service to human health. Hospital management & professionals define their service concept with the significance attached to the belief. The management is concerned with both medical statistics and, above all, the satisfaction of the patients. Patients from other countries are well looked after. The hospital offers international patients a relaxing and secure environment in terms of psychology, comfort, and health.
The hospital's primary purpose is to provide world-class patient-centered health care through our highly responsible team who can produce information and use it appropriately. With its university-based scientific infrastructure and competent health care, the hospital's management has long-term plans for it, with a desire to be an innovative and leading health institution that is regarded as a reference in the country and around the world. Several value-added services and quality policies are available at the facility. To mention a few, the hospital is open to development and technology, continuously measuring and improving, training qualified health professionals, caring about patient and employee satisfaction, and becoming mobilized to bring an environment of reliable diagnosis, treatment, and care to the majority of the society.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Turkey for Hypertrophic Cardiomyopathy Treatment?
- Experienced Cardiac Specialists: Turkey has cardiologists, electrophysiologists, cardiac surgeons, and specialists experienced in managing complex heart-muscle disorders.
- Advanced Cardiac Imaging: Major centres may offer advanced echocardiography, cardiac MRI, CT, and ambulatory rhythm monitoring.
- Specialised HCM Management: Appropriate patients may have access to medicines, cardiac myosin inhibitors, septal myectomy, alcohol septal ablation, and ICD implantation.
- Advanced Electrophysiology Services: Specialist centres can evaluate and manage arrhythmias and assess the need for ICDs.
- Multidisciplinary Care: Cardiology, electrophysiology, cardiac surgery, genetics, imaging, rehabilitation, and other specialists can collaborate for complex cases.
- Genetic Evaluation: Selected patients and families can undergo genetic counselling and testing where appropriate.
- Personalised Treatment: Management is tailored according to symptoms, obstruction, heart function, arrhythmia risk, and genetic or family history.
- International Patient Support: Many major Turkey hospitals offer assistance with appointments, treatment coordination, accommodation, and follow-up for international patients.
Frequently Asked Questions
Reviewer
Dr. Nityanand Tripathi
Interventional Cardiologist
29 Years of Experience
With a rich experience of more than 29 years, Dr. Nityanand has gained a vast spectrum of skills and expertise in performing all types of complex cardiac procedures. He is an expert in clinical & interventional cardiology and electrophysiology. He studied his medicine (MBBS) and MD from the Institute of Medical Sciences of Banaras Hindu University, Varanasi, and later completed his DM in Cardiology from the prestigious King George Medical University, Lucknow. View More
Last Reviewed - January 2026